Sarepta Therapeutics, Inc.  (DE) Share Price

Sarepta Therapeutics, Inc. (DE) Share Price

NASDAQ: SRPT | Small Cap
$14.78
-$0.32 (-2.09%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Sarepta Therapeutics, Inc. (DE) Stock Performance

Open
$15.05
Prev. Close
$15.10
Circuit Range
N/A
Day Range
$14.59 - $15.05
Year Range
$14.59 - $24.61
Volume
87,860
Average Traded
$14.82

Sarepta Therapeutics, Inc. (DE) Share Price Today

As of 18 November 2026, Sarepta Therapeutics, Inc. (DE)'s share price is $14.78. The stock opened at $15.05, compared to its previous close of $15.10. During today's trading session, Sarepta Therapeutics, Inc. (DE)'s share price traded between $14.59 and $15.05, with an average price of $14.82. Over the past 52 weeks, the stock has recorded a high of $24.61 and a low of $14.59. In terms of performance, Sarepta Therapeutics, Inc. (DE)'s share price has declined by 17.38% over the last six months and is down 30.71% on a year-on-year basis.

Sarepta Therapeutics, Inc. (DE) Share Price Chart

Line chart of the Sarepta Therapeutics, Inc. (DE) price trend over the selected period. The price fell overall, ranging from 14.59 to 15.13, ending at 14.78.
$14.59$15.05
L
Show Current Price
H

Sarepta Therapeutics, Inc. (DE) Stock Fundamentals & Key Indicators

Market Cap
$1.48B
PE Ratio (TTM)
109.92
Dividend Yield
0.00%
EPS (TTM)
$0.14
Revenue (TTM)
$2.20T
Return On Equity (TTM)
0.97%
Profit Margin
-32.45%
Debt to Equity
0.56
Quarterly Earnings Growth YoY
89.94%

Sarepta Therapeutics, Inc. (DE) Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$442.93$730.80$401.25$381.35
Net Profit-$282.85$330.96-$4.89-$28.46
Net Profit Margin-63.86%45.29%-1.22%-7.46%
Income ChangeN/A217.01%-101.48%-482.00%

Sarepta Therapeutics, Inc. (DE) Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$933.01$1243.34$1901.98$2198.24
Net Profit-$703.49-$535.98$235.24-$713.41
Net Profit Margin-75.40%-43.11%12.37%-32.45%
Income ChangeN/A23.81%143.89%-403.27%

About Sarepta Therapeutics, Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Sarepta Therapeutics, Inc. (DE) Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$18.65
$14.77
-20.61%
Oct 2026
$17.98
$18.61
+2.00%
Sep 2026
$21.07
$18.24
-15.48%
Aug 2026
$14.99
$21.58
+45.37%
Jul 2026
$18.30
$14.85
-17.48%
Jun 2026
$17.61
$17.99
+0.56%
May 2026
$20.97
$17.89
-14.28%
Apr 2026
$21.85
$20.87
-4.00%
Mar 2026
$16.12
$21.74
+29.71%
Feb 2026
$19.91
$16.76
-17.54%
Jan 2026
$21.85
$20.32
-5.53%
Dec 2025
$20.91
$21.52
+0.87%

SRPT Share Price FAQs